[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

 Letters to Industry / Healthcare Providers / Clinical Investigators
Therapeutic Biological Products

horizonal rule

Letter to Abbott Laboratories Concerning Serious Manufacturing Deficiencies with Abbokinase -7/14/1999 (PDF), (Text)

  • Serious Manufacturing Deficiencies with Abbokinase Prompt FDA Letter to Abbott Labs - 7/16/1999

  • Update on Abbokinase (Urokinase) - 3/22/1999

    Warning Letter - Abbokinase (Urokinase) - 3/19/1999 (PDF), (Text)

  • Update on Abbokinase (Urokinase) - 3/16/1999 - Updated information is provided in the March 22, 1999 Update on Abbokinase Information Sheet

    Dear Healthcare Provider: Important Drug Warning: Safety information regarding the use of Abbokinase (Urokinase) - 1/25/1999 - (PDF) - Updated information is provided in the March 16, 1999 Update on Abbokinase Information Sheet

  • Difficulties in Obtaining Sufficient Amounts of Urokinase (Abbokinase) - 12/11/1998 - Updated information is provided in the January 25, 1999 Dear Healthcare Provider letter

    • Updated May 16, 2002

    Back to Top     Back to Index

    Date created: September 25, 2003
    horizonal rule

    CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
    FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

    FDA/Center for Drug Evaluation and Research